ethinylestradiol/levonorgestrel

thumb|Rigevidon, an example of a combined ethinylestradiol/levonorgestrel contraceptive pill

Clinical Trials

87 registered

COMPLETED
Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · NCT00511784
PHASE3COMPLETED
LCS16 vs. COC User Satisfaction and Tolerability StudyBayer · NCT03074045
PHASE3COMPLETED
Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral ContraceptionWyeth is now a wholly owned subsidiary of Pfizer · NCT00248963
PHASE1COMPLETED
A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.Novo Nordisk A/S · NCT06188026
PHASE1/PHASE2COMPLETED
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"Estetra · NCT02957630
PHASE1RECRUITING
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or ObesityAstraZeneca · NCT07013643

via ClinicalTrials.gov

Wikidata facts

Instance of: combination drug
Has part: levonorgestrel

via Wikidata · CC0

~2 min read

Encyclopedic overview

2 sections

Contents

See also
References

thumb|Rigevidon, an example of a combined ethinylestradiol/levonorgestrel contraceptive pill

Ethinylestradiol/levonorgestrel (EE/LNG) is a combined birth control pill made up of ethinylestradiol (an estrogen) and levonorgestrel (a progestin). It is used for birth control, symptoms of menstruation, endometriosis, and as emergency contraception. It is taken by mouth. Some preparations of EE/LNG additionally contain an iron supplement in the form of ferrous bisglycinate or ferrous fumarate.

Excerpted from Wikipedia’s “ethinylestradiol/levonorgestrel” article, available under the CC BY-SA 4.0 licence.